lobbying_activities: 961694

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
961694	90782503-1dcf-4071-a247-9997dc55b452	Q2	THE DUBERSTEIN GROUP INC.	12675	AMERICA'S HEALTH INSURANCE PLANS	2010	second_quarter	PHA	Antitrust exemption for pharmacies - HR 1204, Community Pharmacy Fairness Act of 2009. Generic drugs - HR 1706, Protecting Consumer Access to Generic Drugs Act of 2009; HR 4899, Supplemental Appropriations Act, 2010; S 369, Preserve Access to Affordable Generics Act. Generic biologics - HR 3590, Patient Protection and Affordable Care Act. Federal Employee Health Benefit Program prescription drugs - HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act. *Prescription drug co-pays and formularies - S 1630, Affordable Access to Prescription Medications Act of 2009.	HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of	100000		0	0	2010-07-19T12:12:35.030000-04:00